Fennec Pharmaceuticals (FENC) Return on Capital Employed Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,577.00 |
| Sep 30, 2025 | 4,129.00 |
| Jun 30, 2025 | 3,957.00 |
| Mar 31, 2025 | 10,473.00 |
| Dec 31, 2024 | 10,769.00 |
| Sep 30, 2024 | 8,120.00 |
| Jun 30, 2024 | 8,520.00 |
| Mar 31, 2024 | 7,186.00 |
| Dec 31, 2023 | -3,382.00 |
| Sep 30, 2023 | -6,595.00 |
| Jun 30, 2023 | -10,623.00 |
| Mar 31, 2023 | -8,927.00 |
| Dec 31, 2022 | -5,413.00 |
| Sep 30, 2022 | -4,124.00 |
| Jun 30, 2022 | -5,431.00 |
| Mar 31, 2022 | 1,455.00 |
| Dec 31, 2021 | -223.00 |
| Sep 30, 2021 | -1,454.00 |
| Jun 30, 2021 | 1,905.00 |
| Mar 31, 2021 | 34,167.00 |
| Dec 31, 2020 | 18,871.00 |
| Sep 30, 2020 | 11,943.00 |
| Jun 30, 2020 | 14,391.00 |
| Mar 31, 2020 | 13,226.00 |
| Dec 31, 2019 | -131,848.00 |
| Sep 30, 2019 | -16,036.00 |
| Jun 30, 2019 | -11,828.00 |
| Mar 31, 2019 | -10,198.00 |
| Dec 31, 2018 | -14,269.00 |
| Mar 31, 2018 | -7,013.00 |
| Dec 31, 2017 | -11,714.00 |
| Dec 31, 2016 | 93,736.00 |